News

  • 20 April 2018

    Gene-edited stem cells reduce HIV risk in non-human primates

    Researchers have found that by genetically editing bone marrow stem cells of pigtail macaques infected with simian/human immunodeficiency virus (SHIV), the size of dormant ‘viral reservoirs’ can be reduced, decreasing...

  • 20 April 2018

    Compound reduces inflammation in stroke patients

    Researchers at the Augusta University Medical College of Georgia have discovered an experimental compound reduces harmful inflammation following a stroke, improving patient outcomes.

  • 20 April 2018

    Summit Therapeutics ends dosing in PhaseOut DMD trial

    Summit Therapeutics has completed patient dosing in the PhaseOut DMD clinical trial, a Phase II study of ezutromid to treat patients with duchenne muscular dystrophy (DMD), the most common and...